Innate Pharma SA - SPONSORED ADS (IPHA)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q3 2024
238K
Holdings value Q3 2024
$544K
Value change Q3 2024
-$8.24K
Grand Portfolio weight change Q3 2024
0%
Number of holders
7
Number of buys Q3 2024
1
Number of sells Q3 2024
-3
Average buys Q3 2024 %
0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 238K $544K -$8.24K $2.29 7
2024 Q2 242K $469K -$47.2K $1.94 8
2024 Q1 254K $731K +$360K $2.88 9
2023 Q4 129K $361K -$531K $2.80 8
2023 Q3 318K $806K +$202K $2.53 8
2023 Q2 235K $734K -$490K $3.14 8
2023 Q1 397K $1.13M -$11.7K $2.85 8
2022 Q4 399K $1.49M -$1.14M $3.73 9
2022 Q3 944K $1.89M -$25.3K $2.00 9
2022 Q2 954K $2.58M -$75.8K $2.70 12
2022 Q1 952K $3.2M -$1.45M $3.36 12
2021 Q4 1.28M $5.85M +$940K $4.56 15
2021 Q3 943K $5.82M +$5.27M $6.17 18
2021 Q2 89.5K $296K -$324K $3.30 5
2021 Q1 176K $760K -$5.09M $4.32 7
2020 Q4 1.4M $5.71M -$1.12M $4.09 4
2020 Q3 1.68M $6.65M -$6.06M $3.90 6
2020 Q2 2.87M $20.3M -$29.6M $7.00 7
2020 Q1 7.34M $49M -$2.48M $6.68 10
2019 Q4 7.71M $49.7M +$49.7M $6.43 11